Orbimed Advisors - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2021$58,916,000
-9.5%
447,859
-11.3%
0.60%
-2.1%
Q1 2021$65,105,000
+16.0%
505,159
+50.1%
0.61%
+24.0%
Q4 2020$56,121,000
-50.5%
336,500
-54.2%
0.49%
-65.5%
Q3 2020$113,348,000
-51.0%
734,500
-53.0%
1.42%
-56.2%
Q2 2020$231,166,000
-37.6%
1,562,986
-52.5%
3.25%
-47.7%
Q1 2020$370,194,000
-20.4%
3,287,400
-1.7%
6.22%
-6.3%
Q4 2019$465,092,000
+29.8%
3,343,100
-10.1%
6.64%
-2.3%
Q3 2019$358,231,000
-19.1%
3,719,173
-3.3%
6.80%
-0.9%
Q2 2019$442,944,000
-5.2%
3,846,673
-3.1%
6.86%
-5.2%
Q1 2019$467,348,000
+82.5%
3,970,673
-2.9%
7.24%
+52.8%
Q4 2018$256,074,000
-13.0%
4,087,373
-1.6%
4.74%
+33.5%
Q3 2018$294,486,000
+0.3%
4,155,891
-5.8%
3.55%
+1.3%
Q2 2018$293,572,000
+33.3%
4,413,291
+31.1%
3.50%
+28.2%
Q1 2018$220,222,000
+63.3%
3,367,3150.0%2.73%
+60.1%
Q4 2017$134,895,000
+10.5%
3,367,3150.0%1.71%
+46.2%
Q3 2017$122,065,000
+30.6%
3,367,3150.0%1.17%
+19.1%
Q2 2017$93,477,000
+22.9%
3,367,315
+23.9%
0.98%
+13.7%
Q1 2017$76,085,000
+38.3%
2,717,3150.0%0.86%
+23.0%
Q4 2016$54,998,000
+24.9%
2,717,315
+24.0%
0.70%
+39.6%
Q3 2016$44,039,000
+51.5%
2,191,0000.0%0.50%
+65.7%
Q2 2016$29,075,000
+605.4%
2,191,000
+885.9%
0.30%
+604.7%
Q1 2016$4,122,000
+1.3%
222,2230.0%0.04%
+16.2%
Q4 2015$4,071,000
+3.5%
222,2230.0%0.04%
-7.5%
Q3 2015$3,933,000
-84.6%
222,223
-84.7%
0.04%
-78.7%
Q2 2015$25,618,000
+1.9%
1,448,9910.0%0.19%
-12.6%
Q1 2015$25,140,0001,448,9910.22%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2021
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders